| Dr Arvind Il Maheshwari, MD | |
|
450 W Highway 22, Barrington, IL 60010-1919 | |
| (847) 381-0123 | |
| Not Available |
| Full Name | Dr Arvind Il Maheshwari |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 10 Years |
| Location | 450 W Highway 22, Barrington, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659767903 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Sherman Hospital | Elgin, IL | Hospital |
| Advocate Good Shepherd Hospital | Barrington, IL | Hospital |
| Advocate Condell Medical Center | Libertyville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.
The first study to use a cannabis-based medicine (CBM) for treating rheumatoid arthritis has found that it has a significant effect on easing pain and on suppressing the disease.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.
› Verified 2 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.
The first study to use a cannabis-based medicine (CBM) for treating rheumatoid arthritis has found that it has a significant effect on easing pain and on suppressing the disease.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.
› Verified 2 days ago
| Entity Name | Midwest Endocrinology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316192685 PECOS PAC ID: 4284799099 Enrollment ID: O20090211000316 |
News Archive
Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.
The first study to use a cannabis-based medicine (CBM) for treating rheumatoid arthritis has found that it has a significant effect on easing pain and on suppressing the disease.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.
› Verified 2 days ago
| Entity Name | Gottlieb Community Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013415603 PECOS PAC ID: 3375442999 Enrollment ID: O20180420000980 |
News Archive
Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.
The first study to use a cannabis-based medicine (CBM) for treating rheumatoid arthritis has found that it has a significant effect on easing pain and on suppressing the disease.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.
› Verified 2 days ago
| Entity Name | Loyola Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376041954 PECOS PAC ID: 6305109547 Enrollment ID: O20180420002063 |
News Archive
Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.
The first study to use a cannabis-based medicine (CBM) for treating rheumatoid arthritis has found that it has a significant effect on easing pain and on suppressing the disease.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arvind Il Maheshwari, MD 29373 Network Pl, Chicago, IL 60673-1293 Ph: (847) 390-5900 | Dr Arvind Il Maheshwari, MD 450 W Highway 22, Barrington, IL 60010-1919 Ph: (847) 381-0123 |
News Archive
Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.
The first study to use a cannabis-based medicine (CBM) for treating rheumatoid arthritis has found that it has a significant effect on easing pain and on suppressing the disease.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.
› Verified 2 days ago
Dr. Avani Tushar Mehta, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27750 W Highway 22 Ste 110, Barrington, IL 60010 Phone: 847-381-4491 Fax: 847-381-4498 | |
Dr. Jeffrey H Freihage, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27750 W Highway 22 Ste 240, Barrington, IL 60010 Phone: 815-206-5700 Fax: 847-382-1771 | |
Dr. Kristine Marie Young, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 426 N Hough St, Barrington, IL 60010 Phone: 847-304-6900 Fax: 847-304-6871 | |
Dr. Michael B Soble, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 27750 W Highway 22, Suite G80, Barrington, IL 60010 Phone: 847-842-0850 Fax: 847-842-0357 | |
Dr. Donald F Cronin, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27750 W Highway 22, Suite 120, Barrington, IL 60010 Phone: 847-655-7264 Fax: 847-655-7262 | |
Stacey L Mckelvey, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 200 Fox Glen Ct, Barrington, IL 60010 Phone: 847-382-7165 Fax: 847-713-8160 | |
Jennifer Louise Vakharia, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1020 S Grove Ave, Barrington, IL 60010 Phone: 630-712-6373 |